Compounds > melatonin
Page last updated: 2024-10-19

melatonin and Apnea, Sleep

melatonin has been researched along with Apnea, Sleep in 20 studies

Research Excerpts

ExcerptRelevanceReference
"Melatonin has been advocated in treatment of sleep disorders, and its beneficial effect has been confirmed in insomnia."6.75Melatonin and sleep-related problems in children with intractable epilepsy. ( Abd-Elhamid, IA; Asaad, T; Elkhayat, HA; Elwakkad, AS; Hassanein, SM; Tomoum, HY, 2010)
"We hypothesised that melatonin may represent a safe somniferous drug for cardiac patients, and assessed the effects of administering 5 mg of melatonin daily before bedtime for 30 days in patients with coronary artery disease (CAD) regarding changes in the nocturnal breathing pattern."5.16Melatonin - a somniferous option which does not aggravate sleep-disordered breathing in cardiac risk patients: a Holter ECG based study. ( Kasprzak, JD; Krzemińska-Pakuła, M; Kurpesa, M; Rechciński, T; Trzos, E; Uznańska-Loch, B; Wierzbowska-Drabik, K, 2012)
" We aimed to investigate the proteins related to oxidative stress, inflammation and apoptosis in liver tissue subjected to IH as a simulation of sleep apnea in conjunction with the administration of either melatonin (MEL, 200 μL/kg) or N-acetylcysteine (NAC, 10 mg/kg)."3.81Antioxidants inhibit the inflammatory and apoptotic processes in an intermittent hypoxia model of sleep apnea. ( Andrade, CF; da Rosa, DP; e Silva, MB; Fiori, CZ; Forgiarini, LF; Marroni, NP; Martinez, D, 2015)
" Switching to morning dosing or to an alternative drug may help."2.82[Sleep disorders in patients with a neurocognitive disorder]. ( Carrier, J; Dang-Vu, TT; Moderie, C, 2022)
"Melatonin has been advocated in treatment of sleep disorders, and its beneficial effect has been confirmed in insomnia."2.75Melatonin and sleep-related problems in children with intractable epilepsy. ( Abd-Elhamid, IA; Asaad, T; Elkhayat, HA; Elwakkad, AS; Hassanein, SM; Tomoum, HY, 2010)
"While some sleep disorders are more challenging to treat, most can be easily managed with adequate interventions."2.61Sleep Disorders. ( K Pavlova, M; Latreille, V, 2019)
" The recognition of the periodicity of biological processes makes the optimal dosing of certain drugs feasible."2.48[Physiological and pathophysiological role of the circadian clock system]. ( Halmos, T; Suba, I, 2012)
"Fibromyalgia has gender, age and probably hormonal associations."2.43Menopause related sleep disorders. ( Eichling, PS; Sahni, J, 2005)
"Patients with dementias, such as Alzheimer's disease (AD), often have nocturnally disrupted sleep."2.42Sleep disorders in Alzheimer's disease and other dementias. ( Bliwise, DL, 2004)
"Non-REM parasomnias are not uncommon conditions in the general population."1.51NREM parasomnias: a treatment approach based upon a retrospective case series of 512 patients. ( d'Ancona, G; Dongol, EM; Drakatos, P; Gildeh, N; Higgins, S; Kent, BD; Leschziner, G; Lyons, E; Macavei, R; Marples, L; Muza, R; Nesbitt, A; Rosenzweig, I; Steier, J; Williams, AJ, 2019)
"The present results suggest that sleep fragmentation and any resultant cognitive deficits are likely not confounded by corresponding deficits in circadian rhythms."1.46Young children with Down syndrome show normal development of circadian rhythms, but poor sleep efficiency: a cross-sectional study across the first 60 months of life. ( Anand, P; Clark, C; Demara, BI; Edgin, JO; Fernandez, F; Nyhuis, CC; Ruby, NF; Spanò, G, 2017)
"Melatonin was successfully used as an alternative treatment."1.35REM sleep behaviour disorder treated with melatonin in a patient with Alzheimer's disease. ( Anderson, KN; Graham, AJ; Jamieson, S; Shneerson, JM, 2008)
"Effective treatments now exist for many sleep disorders, such as OSA and RLS, and a major breakthrough in the treatment of narcolepsy seems imminent."1.32Sleep disorders. ( Fisch, BJ; Olejniczak, PW, 2003)
"1."1.30Melatonin secretion and excretion in patients with obstructive sleep apnea syndrome. ( Röjdmark, S; Svanborg, E; Wetterberg, L; Wikner, J, 1997)
"Melatonin has a strong circadian rhythm with high values during the night-time and low values in the afternoon."1.30Afternoon serum-melatonin in sleep disordered breathing. ( Micic, S; Strøm, J; Ulfberg, J, 1998)

Research

Studies (20)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (20.00)18.2507
2000's5 (25.00)29.6817
2010's9 (45.00)24.3611
2020's2 (10.00)2.80

Authors

AuthorsStudies
Moderie, C1
Carrier, J1
Dang-Vu, TT1
Kennert, BA1
Harshorne, TS1
Kanouse, S1
Johnson, C1
Fernandez, F1
Nyhuis, CC1
Anand, P1
Demara, BI1
Ruby, NF1
Spanò, G1
Clark, C1
Edgin, JO1
Drakatos, P1
Marples, L1
Muza, R1
Higgins, S1
Gildeh, N1
Macavei, R1
Dongol, EM1
Nesbitt, A1
Rosenzweig, I1
Lyons, E1
d'Ancona, G1
Steier, J1
Williams, AJ1
Kent, BD1
Leschziner, G1
K Pavlova, M1
Latreille, V1
da Rosa, DP1
Forgiarini, LF1
e Silva, MB1
Fiori, CZ1
Andrade, CF1
Martinez, D1
Marroni, NP1
Mahlberg, R1
Elkhayat, HA1
Hassanein, SM1
Tomoum, HY1
Abd-Elhamid, IA1
Asaad, T1
Elwakkad, AS1
Rechciński, T1
Uznańska-Loch, B1
Trzos, E1
Wierzbowska-Drabik, K1
Krzemińska-Pakuła, M1
Kasprzak, JD1
Kurpesa, M1
Szymański, FM1
Halmos, T1
Suba, I1
Olejniczak, PW1
Fisch, BJ1
Bliwise, DL1
Eichling, PS1
Sahni, J1
Anderson, KN1
Jamieson, S1
Graham, AJ1
Shneerson, JM1
Entzian, P1
Linnemann, K1
Schlaak, M1
Zabel, P1
Wikner, J1
Svanborg, E1
Wetterberg, L1
Röjdmark, S1
Ulfberg, J1
Micic, S1
Strøm, J1
Manber, R1
Armitage, R1
Dauvilliers, Y1
Touchon, J1

Clinical Trials (5)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Study of the Influence of an Osteopathic Treatment Protocol on the Improvement of Sleep: a Double-blind Randomized Controlled Trial[NCT05899972]50 participants (Anticipated)Interventional2023-09-01Not yet recruiting
Effect of Melatonin Supplementation on Sleep and Health of Children With Cerebral Palsy[NCT04392063]40 participants (Actual)Interventional2016-06-30Completed
Sleepiness and the Effects of CPAP on Salivary Cortisol and Alpha-Amylase Levels in Patients With Sleep Apnea[NCT01196117]18 participants (Actual)Interventional2004-11-15Completed
Benefice Assessment of Repetitive Transcranial Magnetic Stimulation Used as an Additional Procedure to Rehabilitation Exercises in Patients Suffering From Fibromyalgia[NCT01308801]42 participants (Actual)Interventional2011-04-30Completed
Evaluation of Spa Therapy in the Treatment of Fibromyalgia : a Randomized, Controlled, Open Multicenter Study[NCT02265029]220 participants (Actual)Interventional2014-09-30Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

Epworth Sleepiness Score (ESS)

Epworth Sleepiness Score (ESS) is a scale to assess sleepiness during waking hours. The scale ranges from 0-24 with higher scores indicative of greater sleepiness. (NCT01196117)
Timeframe: Difference between Baseline(Day 0) and Average of Day 1,7,14.

Interventionunits on a scale (Median)
14 Days of Placebo Therapy, Then CPAP10.7
14 Days of CPAP Therapy8.9

Salivary Cortisol in Participants Who Used Continuous Positive Airway Pressure (CPAP) at ~ 7am, Day 7

Salivary Cortisol was measured by enzyme-linked immunosorbent assay. The reference range for healthy adults is <4.2 nmol/l. (NCT01196117)
Timeframe: Day 7, 7am

Interventionnmol/l (Mean)
CPAP>= 3 Hours Per Night9.9
CPAP<3 Hours Per Night13.3

Salivary Cortisol in Participants Who Used Continuous Positive Airway Pressure (CPAP) at ~11pm, Day 0

Salivary Cortisol was measured by enzyme-linked immunosorbent assay. The reference range for healthy adults is <4.2 nmol/l. (NCT01196117)
Timeframe: Day 0, 11pm

Interventionnmol/l (Median)
CPAP>= 3 Hours Per Night3.2
CPAP<3 Hours Per Night1.2

Salivary Cortisol in Participants Who Used Continuous Positive Airway Pressure (CPAP) at ~11pm, Day 1

Salivary Cortisol was measured by enzyme-linked immunosorbent assay. The reference range for healthy adults is <4.2 nmol/l. (NCT01196117)
Timeframe: Day 1, 11pm

Interventionnmol/l (Median)
CPAP>= 3 Hours Per Night2.2
CPAP<3 Hours Per Night1.8

Salivary Cortisol in Participants Who Used Continuous Positive Airway Pressure (CPAP) at ~11pm, Day 14

Salivary Cortisol was measured by enzyme-linked immunosorbent assay. The reference range for healthy adults is <4.2 nmol/l. (NCT01196117)
Timeframe: Day 14, 11pm

Interventionnmol/l (Median)
CPAP>= 3 Hours Per Night1.9
CPAP<3 Hours Per Night2.2

Salivary Cortisol in Participants Who Used Continuous Positive Airway Pressure (CPAP) at ~11pm, Day 7

Salivary Cortisol was measured by enzyme-linked immunosorbent assay. The reference range for healthy adults is <4.2 nmol/l. (NCT01196117)
Timeframe: Day 7, 11pm

Interventionnmol/l (Median)
CPAP>= 3 Hours Per Night3.0
CPAP<3 Hours Per Night2.5

Salivary Cortisol in Participants Who Used Continuous Positive Airway Pressure (CPAP) at ~7am, Day 0

Salivary Cortisol was measured by enzyme-linked immunosorbent assay. The reference range for healthy adults is <4.2 nmol/l. (NCT01196117)
Timeframe: Day 0, 7am

Interventionnmol/l (Median)
CPAP>= 3 Hours Per Night12.5
CPAP<3 Hours Per Night12.1

Salivary Cortisol in Participants Who Used Continuous Positive Airway Pressure (CPAP) at ~7am, Day 1

Salivary Cortisol was measured by enzyme-linked immunosorbent assay. The reference range for healthy adults is <4.2 nmol/l. (NCT01196117)
Timeframe: Day 1, 7am

Interventionnmol/l (Median)
CPAP>= 3 Hours Per Night7.4
CPAP<3 Hours Per Night13.6

Salivary Cortisol in Participants Who Used Continuous Positive Airway Pressure (CPAP) at ~7am, Day 14

Salivary Cortisol was measured by enzyme-linked immunosorbent assay. The reference range for healthy adults is <4.2 nmol/l. (NCT01196117)
Timeframe: Day 14, 7am

Interventionnmol/l (Median)
CPAP>= 3 Hours Per Night9.2
CPAP<3 Hours Per Night15.0

Reviews

7 reviews available for melatonin and Apnea, Sleep

ArticleYear
[Sleep disorders in patients with a neurocognitive disorder].
    L'Encephale, 2022, Volume: 48, Issue:3

    Topics: Alzheimer Disease; Chronobiology Disorders; Humans; Melatonin; REM Sleep Behavior Disorder; Restless

2022
Sleep Disorders.
    The American journal of medicine, 2019, Volume: 132, Issue:3

    Topics: Central Nervous System Depressants; Central Nervous System Stimulants; Chronobiology Disorders; Cogn

2019
[Physiological and pathophysiological role of the circadian clock system].
    Orvosi hetilap, 2012, Sep-02, Volume: 153, Issue:35

    Topics: Aging; ARNTL Transcription Factors; Blood Coagulation Disorders; Cardiovascular Diseases; Circadian

2012
Sleep disorders in Alzheimer's disease and other dementias.
    Clinical cornerstone, 2004, Volume: 6 Suppl 1A

    Topics: Accidental Falls; Alzheimer Disease; Antipsychotic Agents; Body Temperature Regulation; Chronobiolog

2004
Menopause related sleep disorders.
    Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2005, Jul-15, Volume: 1, Issue:3

    Topics: Depression; Estrogen Replacement Therapy; Estrogens; Female; Fibromyalgia; Humans; Hydrocortisone; M

2005
Sex, steroids, and sleep: a review.
    Sleep, 1999, Aug-01, Volume: 22, Issue:5

    Topics: Animals; Depressive Disorder; Female; gamma-Aminobutyric Acid; Gonadal Steroid Hormones; Humans; Hyp

1999
[Sleep in fibromyalgia: review of clinical and polysomnographic data].
    Neurophysiologie clinique = Clinical neurophysiology, 2001, Volume: 31, Issue:1

    Topics: Adult; Antidepressive Agents, Tricyclic; Anxiety; Arousal; Circadian Rhythm; Depression; Female; Fib

2001
[Sleep in fibromyalgia: review of clinical and polysomnographic data].
    Neurophysiologie clinique = Clinical neurophysiology, 2001, Volume: 31, Issue:1

    Topics: Adult; Antidepressive Agents, Tricyclic; Anxiety; Arousal; Circadian Rhythm; Depression; Female; Fib

2001
[Sleep in fibromyalgia: review of clinical and polysomnographic data].
    Neurophysiologie clinique = Clinical neurophysiology, 2001, Volume: 31, Issue:1

    Topics: Adult; Antidepressive Agents, Tricyclic; Anxiety; Arousal; Circadian Rhythm; Depression; Female; Fib

2001
[Sleep in fibromyalgia: review of clinical and polysomnographic data].
    Neurophysiologie clinique = Clinical neurophysiology, 2001, Volume: 31, Issue:1

    Topics: Adult; Antidepressive Agents, Tricyclic; Anxiety; Arousal; Circadian Rhythm; Depression; Female; Fib

2001

Trials

2 trials available for melatonin and Apnea, Sleep

ArticleYear
Melatonin and sleep-related problems in children with intractable epilepsy.
    Pediatric neurology, 2010, Volume: 42, Issue:4

    Topics: Adolescent; Bruxism; Child; Child, Preschool; Epilepsy; Female; Humans; Hypnotics and Sedatives; Mal

2010
Melatonin - a somniferous option which does not aggravate sleep-disordered breathing in cardiac risk patients: a Holter ECG based study.
    Kardiologia polska, 2012, Volume: 70, Issue:1

    Topics: Aged; Aged, 80 and over; Central Nervous System Depressants; Circadian Rhythm; Coronary Artery Disea

2012

Other Studies

11 other studies available for melatonin and Apnea, Sleep

ArticleYear
Parent survey of sleep problems among children with CHARGE syndrome.
    Research in developmental disabilities, 2020, Volume: 101

    Topics: Adolescent; Anxiety; Central Nervous System Depressants; CHARGE Syndrome; Child; Child, Preschool; C

2020
Young children with Down syndrome show normal development of circadian rhythms, but poor sleep efficiency: a cross-sectional study across the first 60 months of life.
    Sleep medicine, 2017, Volume: 33

    Topics: Actigraphy; Child; Child, Preschool; Circadian Rhythm; Cross-Sectional Studies; Down Syndrome; Femal

2017
NREM parasomnias: a treatment approach based upon a retrospective case series of 512 patients.
    Sleep medicine, 2019, Volume: 53

    Topics: Adult; Antioxidants; Benzodiazepines; Cognitive Behavioral Therapy; Female; Humans; Male; Melatonin;

2019
Antioxidants inhibit the inflammatory and apoptotic processes in an intermittent hypoxia model of sleep apnea.
    Inflammation research : official journal of the European Histamine Research Society ... [et al.], 2015, Volume: 64, Issue:1

    Topics: Acetylcysteine; Animals; Antioxidants; Apoptosis; Caspases; Disease Models, Animal; Hypoxia; Hypoxia

2015
[Sleep Disturbances in the Elderly].
    Deutsche medizinische Wochenschrift (1946), 2016, Volume: 141, Issue:16

    Topics: Aged; Aged, 80 and over; Aging; Cataract; Circadian Rhythm; Humans; Melatonin; Sleep Apnea Syndromes

2016
[Comment to article Pacjent z OSA - o czym warto pamiętać?].
    Kardiologia polska, 2012, Volume: 70, Issue:1

    Topics: Central Nervous System Depressants; Coronary Artery Disease; Female; Humans; Male; Melatonin; Sleep

2012
Sleep disorders.
    The Medical clinics of North America, 2003, Volume: 87, Issue:4

    Topics: Adult; Aged; Antioxidants; Cheyne-Stokes Respiration; Chronobiology Disorders; Chronotherapy; Disord

2003
REM sleep behaviour disorder treated with melatonin in a patient with Alzheimer's disease.
    Clinical neurology and neurosurgery, 2008, Volume: 110, Issue:5

    Topics: Aged; Alzheimer Disease; Diagnosis, Differential; Hormones; Humans; Male; Melatonin; Polysomnography

2008
Obstructive sleep apnea syndrome and circadian rhythms of hormones and cytokines.
    American journal of respiratory and critical care medicine, 1996, Volume: 153, Issue:3

    Topics: Adult; Aged; Cells, Cultured; Circadian Rhythm; Cytokines; Female; Hormones; Humans; Hydrocortisone;

1996
Melatonin secretion and excretion in patients with obstructive sleep apnea syndrome.
    Sleep, 1997, Volume: 20, Issue:11

    Topics: Adult; Aged; Body Mass Index; Circadian Rhythm; Humans; Male; Melatonin; Middle Aged; Norepinephrine

1997
Afternoon serum-melatonin in sleep disordered breathing.
    Journal of internal medicine, 1998, Volume: 244, Issue:2

    Topics: Adult; Bedding and Linens; Case-Control Studies; Circadian Rhythm; Female; Humans; Male; Melatonin;

1998